FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045521574> ?p ?o ?g. }

• W2045521574 endingPage "351" @default.
• W2045521574 startingPage "343" @default.
• W2045521574 abstract "Previous studies have shown that approximately 50% patients at risk of cardiovascular disease do not achieve lipid management goals. Thus, improvements dyslipidemia management are needed. We investigated the clinical choice and efficacy of second-line treatments for dyslipidemia in the Japanese clinical setting. Using a retrospective cohort design, we collected lipid profile data from patients who had been treated with hypolipidemic agents at a stable dosage for at least 12 weeks. These patients had then been administered a second-line treatment for dyslipidemia because they had not achieved the low-density lipoprotein cholesterol (LDL-C) management goals. We included data from 641 patients in our analysis. The top three choices for second-line treatment were adding ezetimibe, switching to strong statins (statin switching), and doubling the original statin dosage (statin doubling). Adding ezetimibe, statin switching, and statin doubling decreased LDL-C levels by 28.2 ± 14.5%, 23.2 ± 24.4%, and 23.5 ± 17.2%, respectively. Among these three strategies, adding ezetimibe decreased LDL-C levels to the maximum extent. In patients with dysglycemia, baseline-adjusted change in hemoglobin A1c (HbA1c) levels decreased slightly in the adding-ezetimibe, statin-switching, and statin-doubling groups, but the differences were not statistically significant among the groups (−0.10 ± 0.62%, −0.22 ± 0.54%, and −0.12 ± 0.52%, p = 0.19). In conclusion, the most common second-line treatment options for dyslipidemia were adding ezetimibe, statin switching, or statin doubling. Adding ezetimibe resulted in the highest reduction in LDL-C levels. These strategies did not increase HbA1c levels when administered with conventional diabetes treatment." @default.
• W2045521574 created "2016-06-24" @default.
• W2045521574 creator A5000058761 @default.
• W2045521574 creator A5008359331 @default.
• W2045521574 creator A5012314113 @default.
• W2045521574 creator A5019461817 @default.
• W2045521574 creator A5024648292 @default.
• W2045521574 creator A5027512095 @default.
• W2045521574 creator A5028959989 @default.
• W2045521574 creator A5030295061 @default.
• W2045521574 creator A5043860608 @default.
• W2045521574 creator A5053454908 @default.
• W2045521574 creator A5065497241 @default.
• W2045521574 creator A5069570092 @default.
• W2045521574 creator A5088387334 @default.
• W2045521574 date "2014-01-01" @default.
• W2045521574 modified "2023-10-16" @default.
• W2045521574 title "Second-line treatments for dyslipidemia in patients at risk of cardiovascular disease" @default.
• W2045521574 cites W1485967434 @default.
• W2045521574 cites W1607804102 @default.
• W2045521574 cites W1878784224 @default.
• W2045521574 cites W1972661406 @default.
• W2045521574 cites W1982444046 @default.
• W2045521574 cites W1992000409 @default.
• W2045521574 cites W1993968922 @default.
• W2045521574 cites W2000071979 @default.
• W2045521574 cites W2018656767 @default.
• W2045521574 cites W2034652497 @default.
• W2045521574 cites W2050504543 @default.
• W2045521574 cites W2054605244 @default.
• W2045521574 cites W2058573028 @default.
• W2045521574 cites W2063908227 @default.
• W2045521574 cites W2078940384 @default.
• W2045521574 cites W2079102359 @default.
• W2045521574 cites W2082643036 @default.
• W2045521574 cites W2089103283 @default.
• W2045521574 cites W2111513060 @default.
• W2045521574 cites W2115169717 @default.
• W2045521574 cites W2116404316 @default.
• W2045521574 cites W2118184073 @default.
• W2045521574 cites W2119236594 @default.
• W2045521574 cites W2126678006 @default.
• W2045521574 cites W2130132335 @default.
• W2045521574 cites W2139324959 @default.
• W2045521574 cites W2150568560 @default.
• W2045521574 cites W2158071129 @default.
• W2045521574 cites W2160609898 @default.
• W2045521574 cites W2167326713 @default.
• W2045521574 cites W3022401702 @default.
• W2045521574 cites W2032525547 @default.
• W2045521574 cites W2124448209 @default.
• W2045521574 doi "https://doi.org/10.1507/endocrj.ej13-0404" @default.
• W2045521574 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24452015" @default.
• W2045521574 hasPublicationYear "2014" @default.
• W2045521574 type Work @default.
• W2045521574 sameAs 2045521574 @default.
• W2045521574 citedByCount "5" @default.
• W2045521574 countsByYear W20455215742017 @default.
• W2045521574 countsByYear W20455215742018 @default.
• W2045521574 countsByYear W20455215742019 @default.
• W2045521574 crossrefType "journal-article" @default.
• W2045521574 hasAuthorship W2045521574A5000058761 @default.
• W2045521574 hasAuthorship W2045521574A5008359331 @default.
• W2045521574 hasAuthorship W2045521574A5012314113 @default.
• W2045521574 hasAuthorship W2045521574A5019461817 @default.
• W2045521574 hasAuthorship W2045521574A5024648292 @default.
• W2045521574 hasAuthorship W2045521574A5027512095 @default.
• W2045521574 hasAuthorship W2045521574A5028959989 @default.
• W2045521574 hasAuthorship W2045521574A5030295061 @default.
• W2045521574 hasAuthorship W2045521574A5043860608 @default.
• W2045521574 hasAuthorship W2045521574A5053454908 @default.
• W2045521574 hasAuthorship W2045521574A5065497241 @default.
• W2045521574 hasAuthorship W2045521574A5069570092 @default.
• W2045521574 hasAuthorship W2045521574A5088387334 @default.
• W2045521574 hasBestOaLocation W20455215741 @default.
• W2045521574 hasConcept C126322002 @default.
• W2045521574 hasConcept C2776329913 @default.
• W2045521574 hasConcept C2776839432 @default.
• W2045521574 hasConcept C2778096610 @default.
• W2045521574 hasConcept C2778657065 @default.
• W2045521574 hasConcept C2779134260 @default.
• W2045521574 hasConcept C71924100 @default.
• W2045521574 hasConcept C90924648 @default.
• W2045521574 hasConceptScore W2045521574C126322002 @default.
• W2045521574 hasConceptScore W2045521574C2776329913 @default.
• W2045521574 hasConceptScore W2045521574C2776839432 @default.
• W2045521574 hasConceptScore W2045521574C2778096610 @default.
• W2045521574 hasConceptScore W2045521574C2778657065 @default.
• W2045521574 hasConceptScore W2045521574C2779134260 @default.
• W2045521574 hasConceptScore W2045521574C71924100 @default.
• W2045521574 hasConceptScore W2045521574C90924648 @default.
• W2045521574 hasIssue "4" @default.
• W2045521574 hasLocation W20455215741 @default.
• W2045521574 hasLocation W20455215742 @default.
• W2045521574 hasOpenAccess W2045521574 @default.
• W2045521574 hasPrimaryLocation W20455215741 @default.
• W2045521574 hasRelatedWork W2017032794 @default.
• W2045521574 hasRelatedWork W2076190764 @default.

• next